A bill to amend the Securities Exchange Act of 1934 to require additional disclosure for pharmaceutical companies.
Disclosing Pharmaceutical Company Windfall Profits Act of 2018
This bill amends the Securities Exchange Act of 1934 to require pharmaceutical companies to make certain public disclosures, including disclosures related to taxation, compensation, dividends, and spending on research and development.
Introduced in Senate
Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line